Mark Harrison is an experienced Associate Principal Scientist at AstraZeneca, where they have worked since 2001. With a solid background in the pharmaceutical industry, Mark has been a key member of various working groups focused on nitrosamines and previously chaired the IQ Nitrite working group. They hold a PhD in Pharmaceutical Analytical Chemistry from Bradford University and possess expertise in techniques such as Liquid Chromatography-Mass Spectrometry and Gas Chromatography-MS. Prior to their current role, Mark served as a Clinical Biochemist at the NHS and worked as an Analytical Chemist at Albright and Wilson.
This person is not in the org chart
This person is not in any teams
This person is not in any offices